Abstract
In honour of Professor Rossi's 80th birthday we review the development of our understanding of the immune and auto-immune nature of the pathogenesis of immune thrombocytopenic purpura (ITP). The immune aspects have been documented by postviral alterations of the cellular and humoral immune system, by new methods of specific auto-antibody detection against platelet glycoproteins and by the therapeutic effect of administering immunoglobulin concentrate from healthy blood donors. The various possible mechanisms of action of immunoglobulin treatment have led to use of this treatment as an alternative for other immune-related disorders. The treatment of severe chronic ITP in children, however, remains unsatisfactory. With a new international clinical and laboratory study of children and adolescents with early chronic ITP we are continuing the investigation of the pathogenesis and treatment of ITP.
Similar content being viewed by others
Abbreviations
- ITP :
-
immune thrombocytopenic purpura
- IVIG :
-
intravenous immunoglobulin
References
Akatsuka, J, Fujisawa K, Ishidoya N, et al. (1989) Long-term follow-up study of children with chronic ITP. Blut 59: 105–108
Anderson JC (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 330: 1560–1564
Andresson JP, Andersson UG (1990) Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 71:372–376
Andrew M, Blanchette VS, Adams M, et al. (1991) A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 120:522–527
Battaieb A, Oksenhendler E, Fromont P, et al. (1989) Immunochemical analysis of platelet auto-antibodies in HIV-related thrombocytopenic purpura: a study of 68 patients. Br J Haematol 73:241–247
Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M, Chan KW, Esseltine D, de Veber B, Israels S, Kobrinsky N, Luke B (1994) Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344:703–707
Cornelius A, Campbell D, Schwart E, Poncz M (1991) Elevated common acute lymphoblastic antigen expression in pediatric immune thrombocytopenic purpura. Am J Pediatr Hematol Oncol 13:57
Dammacco F, Jodice G, Campobasso N (1986) Treatment of adult patients with ITP with intravenous immunoglobulin; effect on T cell subsets and PWM induced antibody synthesis in vitro. Br J Haematol 62:125–135
Dwyer JM (1992) Manipulating the immune system with immune globulin. N Engl J Med 326:107–116
Fateh-Moghadem A, Wick M, Besinger U, Geursen RC (1984) High dose intravenous gammaglobulin for myasthenia gravis. Lancet I:848–849
Fehr J, Hofmann V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous gammaglobulin. N Engl J Med 206: 1254–1258
Griffin DE, Moench TR, Johnston RT, et al. (1986) Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin Immunol Immunopathol 40:305–312
Imbach P, Barandun S, d'Apuzzo V, et al. (1986) High-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet I:1228–1231
Imbach P, Wagner HP, Berchtold W, et al. (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet II:464–468
Imbach P, Tani P, McMillan R, et al. (1991) Different forms of chronic ITP in children defined by antiplatelet autoantibodies. J Pediatr 118:535–539
Imholz B, Imbach P, Baumgartner C, et al. (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 56:63–68
Karpatkin S, Nardi M, Lennette ET, et al. (1988) Antihuman immunodeficiency virus type 1 antibody complexes on plate- lets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci USA 85:9763–9767
Kurtzman G, Frickhofen N, Kimbali J, et al. (1989) Pure red-cell aplasia of 10 years' duration due t persistent parvovirus B 19 infection and its cure with immunoglobulin therapy. N Engl J Med 321:519–523
Leung DYM, Cotran RS, Kurf-Jones E, Burns JC, Newburger JW, Pober JS (1989) Endothelial cell activation and high interleukin-secretion in the pathogenesis of acute Kawasaki disease. Lancet (:1298–1302
McGuire WA, Yang HH, Bruno E, et al. (1987) Treatment of antibody mediated pure red cell aplasia with high dose intravenous gammaglobulin. N Engl J Med 317:1004–1008
McMillan R, Tani P, Millard F, et al. (1987) Platelet-accoxiated and plasma antiglycoprotein auto-antibodies in chronic ITP. Blood 70:1040–1045
McVerry BA, Spearing R, Smith A (1985) SLE anticoagulant; transient inhibition by high dose immunoglobulin infusion. Br J Hematol 9:49–58
NIH Consensus Conference (1990) Intravenous immune globulin: prevention and treatment of disease JAMA 264: 3189–3193
Nugent D, English M, Hawkins D, Pendergrass T, Tarantino M (1994) High dose dexamethasone therapy for pediatric patients with retradory immune-mediated thrombocytopenic purpura (ITP). Blood 94 [Suppl. 1]:186A (Abstract No. 731)
Rhodes G, Rumpold H, Kurki P, et al. (1987) Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. J Exp Med 165:1026–1040
Ross C, Hansen MB, Schyberg T, Berk K (1990) Autoantibodies to crude human leukocyte interferon (IFN), native human IFN, recombinant human IFN alpha 2b and human IFN gamma in healthy blood donors. Clin Ecp Immunol 32:695–701
Sandilands GP, althrah HI, Templeton G, et al. (1987) In vivo and in vitro blocking of human lymphocyte Fc receptors by intravenous gammaglobulin. J Clin Lab Immunol 23:109–115
Semple JW, Freedman J (1991) Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 78: 2619–2625
Sing GK, Ruscetti FW (1990) Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 25:159–172
Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE (1985) Antiidiotypic suppression of auto-antibodies to factor VIII anti-hemophilic factor by high dose intravenous gammaglobulin. Lancet II:765–768
Tamary H, Kaplinsky C, Levy I, Cohen IJ, Yaniv I, Stark B, Goshen Y, zaizov R (1994) Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up. Acta Pediatr 83: 931–934
Van der Harst D, de Jong D, Limpens J, et al. (1990) Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura. Blood 76:2321–2326
Van der Lelie J, Lange JMA, Vos JJE, et al. (1987) Autoimmunity against blood cells in human immunodeficiency virus (HIV) infection. Br J Haematol 67:109–114
Walsh CM, Nardi MA, Karpatkin S (1984) On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med 311: 635–639
Young N (1990) Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 25:159–172
Young N, Mortimer P (1984) Viruses and bone marrow failure. Blood 63: 729–737
Gianella-Borradori A, Hirt A, Lüthi A, Wagner HP, Imbach P (1994) Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin; a case report. Blut 48:409–413
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imbach, P., Akatsuka, J., Blanchette, V. et al. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 154 (Suppl 4), S60–S64 (1995). https://doi.org/10.1007/BF02191508
Issue Date:
DOI: https://doi.org/10.1007/BF02191508